S'abonner

Does atopic dermatitis cause food allergy? A systematic review - 06/04/16

Doi : 10.1016/j.jaci.2015.10.049 
Teresa Tsakok, MRCP, MA a, , Tom Marrs, MRCPCH, MSc b, c, , Mahrose Mohsin, MD d, Susannah Baron, MRCP d, George du Toit, FRCPCH b, c, Stephen Till, FRCP, PhD c, Carsten Flohr, FRCP, FRCPCH, PhD a,
a St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom 
b Department of Children's Allergies, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom 
c Division of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom 
d Department of Dermatology, East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom 

Corresponding author: Carsten Flohr, FRCP, FRCPCH, PhD, St John's Institute of Dermatology, St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, United Kingdom.St John's Institute of DermatologySt Thomas' HospitalWestminster Bridge RoadLondonSE1 7EHUnited Kingdom

Abstract

Background

The association between atopic dermatitis (AD) and food allergy (FA) is not fully understood, although a causal relationship has been suggested. This has important implications for prevention and treatment.

Objective

We aimed to review the association between AD and FA, the effect of FA on AD severity, chronicity, and age of onset, and the temporal relationship between the two.

Methods

Medline and Embase were systematically searched from inception to November 2014 for studies investigating both AD and FA.

Results

Sixty-six studies were identified. Eighteen were population-based, 8 used high-risk cohorts, and the rest comprised patients with either established AD or FA. In population-based studies, the likelihood of food sensitization was up to 6 times higher in patients with AD versus healthy control subjects at 3 months of age (odds ratio, 6.18; 95% CI, 2.94-12.98; P < .001). Other population-based studies reported that up to 53% of subjects with AD were food sensitized, and up to 15% demonstrated signs of FA on challenge. Meanwhile, studies including only patients with established AD have reported food sensitization prevalences up to 66%, with challenge-proven FA prevalences reaching up to 81%. Sixteen studies suggested that FA is associated with a more severe AD phenotype. Six studies indicated that AD of earlier onset or increased persistence is particularly associated with FA. Finally, one study found that AD preceded the development of FA.

Conclusions

This systematic review confirms a strong and dose-dependent association between AD, food sensitization, and FA. AD of increased severity and chronicity is particularly associated with FA. There is also evidence that AD precedes the development of food sensitization and allergy, in keeping with a causal relationship.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, eczema, food allergy, food sensitization

Abbreviations used : AD, aOR, DBPCFC, FA, FLG, OFC, OR, PPV, sIgE, SPT, UK


Plan


 Disclosure of potential conflict of interest: S. Baron has served as a consultant for Abbvie, receives payment for lectures regarding psychodermatology training and also received travel support from Abbvie. G. du Toit receives research funding from National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH), Food Allergy & Research Education (FARE), the MRC & Asthma UK Centre, the UK Department of Health through the NIHR, the National Peanut Board (NPB), and Osem and received grants from UK Food Standards Agency (FSA) during the conduct of the study. S. Till serves as a consultant for ALK-Abelló, receives payment for lectures for Thermo Fisher, and receives unrestricted research funding from ALK-Abelló. C. Flohr serves as a consultant for Roche/Regeneron and has received payments for lecture from Nutricia. The rest of the authors declare that they have no relevant conflicts of interest.


© 2016  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 137 - N° 4

P. 1071-1078 - avril 2016 Retour au numéro
Article précédent Article précédent
  • Prenatal, perinatal, and childhood vitamin D exposure and their association with childhood allergic rhinitis and allergic sensitization
  • Supinda Bunyavanich, Sheryl L. Rifas-Shiman, Thomas A. Platts-Mills, Lisa Workman, Joanne E. Sordillo, Carlos A. Camargo, Matthew W. Gillman, Diane R. Gold, Augusto A. Litonjua
| Article suivant Article suivant
  • Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
  • James Krueger, James D. Clark, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Inna Cueto, Claire Q. Wang, Huaming Tan, Robert Wolk, Scott T. Rottinghaus, Maryann Z. Whitley, Hernan Valdez, David von Schack, Shawn P. O'Neil, Padmalatha S. Reddy, Svitlana Tatulych, A3921147 Study Investigators

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.